Fig. 2From: Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional studyChange in CSF parameters at 24-week follow-up. A: Change in CSF WBC at 24-week follow-up. B: Change in CSF protein at 24-week follow-up. Rapid reduction in the WBC and protein level in CSF was observed following lenalidomide therapy. Red dotted lines represent the range of normal reference values for the WBC count and protein level in CSF. W: week. WBC: white blood cell; CSF: cerebrospinal fluidBack to article page